http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2008128350-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C335-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-30
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-30
filingDate 2006-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2010-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2008128350-A
titleOfInvention DIPHENYL UREA DERIVATIVES
abstract 1. The compound of General formula I! ! wherein ! R is chloro or bromo; ! X is oxygen or sulfur; ! and its pharmaceutically acceptable salts. ! 2. The compound of formula I according to claim 1, in which R is chlorine. ! 3. The compound according to claim 1, in which X denotes oxygen. ! 4. The compound according to claim 2, in which X denotes oxygen,! 5. The compound according to claim 1, representing 1- (3-fluoro-5-trifluoromethylphenyl) -3- (4-chloro-3-trifluoromethylphenyl) urea and its pharmaceutically acceptable salts. ! 6. A pharmaceutical composition for controlling infections, comprising a compound according to any one of claims 1 to 5, and conventional carriers and excipients. ! 7. A pharmaceutical composition for controlling infections caused by aerobic and anaerobic gram-positive and anaerobic gram-negative pathogens, containing the compound according to any one of claims 1 to 5, and conventional carriers and excipients. ! 8. The compound according to any one of claims 1 to 5, intended for use as a medicine for combating infections. ! 9. The compound according to any one of claims 1 to 5, intended for use as a medicine for combating infections caused by aerobic and anaerobic gram-positive and anaerobic gram-negative pathogens. ! 10. The use of one or more compounds according to any one of claims 1 to 5, as active ingredients, for the preparation of pharmaceutical compositions intended for the treatment or prevention of infections. ! 11. The use of claim 10, for the fight against infections caused by aerobic and anaerobic gram-positive and anaerobic gram-negative pathogens. ! 12. The use according to claim 11, to combat ba
priorityDate 2005-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419887687
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455695671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16126823
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977

Total number of triples: 29.